G3-VC-PAB-DMEA-Duocarmycin DM

• UNSPSC Description:

  G3-VC-PAB-DMEA-Duocarmycin DM (Compound LD-1) is a duocarmycin-based linker molecule that can be used for ADC preparation[1]..

• Target Antigen:

  Drug-Linker Conjugates for ADC

• Type:

  ADC Related

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/g3-vc-pab-dmea-duocarmycin-dm.html

• Solubility:

  10 mM in DMSO

• Smiles:

  ClC[C@H]1C2=C(C=C(C3=CC=CC=C32)OC(N(C)CCN(C)C(OCC4=CC=C(C=C4)NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CNC(CNC(CN)=O)=O)=O)=O)=O)=O)=O)N(C1)C(C5=CC6=CC(OCCN(C)C)=CC=C6N5)=O

• Molecular Weight:

  1154.70

• References & Citations:

  [1]Carl Deutsch, et al. Polythérapie utilisant des agents d'alkylation d'adn et des inhibiteurs d'atr.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2415664-00-3